T1	Participants 218 253	As many of these patients are older
T2	Participants 561 593	in animal models and in patients
T3	Participants 652 709	49 patients scheduled for orthopaedic or vascular surgery
T4	Participants 1022 1046	Patients were ineligible
T5	Participants 1307 1332	only in the control group
T6	Participants 1393 1445	ignificantly elevated in the 400 and 500 U/kg groups
T7	Participants 2187 2243	mostly reported in patients with terminal kidney failure
